Workflow
Fannie Mae Reports Net Income of $3.9 Billion for Third Quarter 2025
Prnewswire· 2025-10-29 19:32
Accessibility StatementSkip Navigation Company Will Host Webcast at 8 A.M. Eastern to Discuss Results WASHINGTON, Oct. 29, 2025 /PRNewswire/ -- Fannie Mae (OTCQB: FNMA)Â today reported its third quarter 2025 financial results and filed its Third Quarter 2025 Form 10-Q with the Securities and Exchange Commission. The filing provides condensed consolidated financial statements for the quarter ended September 30, 2025. The following documents are now available on Fannie Mae's website at fanniemae.com/financial ...
Sethi: Thermo Fisher is a world-class compounder you want in your portfolio
Youtube· 2025-10-29 19:31
Let's bring in Sarra Seth, managing partner and portfolio manager at Douglas C. Lane and Associates. He's also a CNBC contributor.Satra, good morning. Good to see you. >> Good morning, Frank.>> All right, we got to start with Nvidia. Uh, looking like it could open above $5 trillion for a market cap when at the opening bell. What does that say to you about the AI trade in this stock in particular.>> Look, I think the AI trade is going very strong. Nvidia's announced quite a few agreements. You you've seen it ...
Flagstar Financial Reports Q3 Loss, NII & Fee Income Decline Y/Y (Revised)
ZACKS· 2025-10-29 19:30
Key Takeaways Flagstar Financial reported Q3 loss per share of 7 cents, compared with the year-ago loss of 69 cents.Lower NII, fee income, and reduced loan and deposit balances pressured overall quarterly results.Non-interest expenses fell nearly 30%, while capital ratios improved year over year.Flagstar Financial, Inc. (FLG) reported third-quarter 2025 adjusted loss per share of 7 cents, compared with the Zacks Consensus Estimate of a loss of 6 cents. It had incurred a loss of 69 cents in the year-ago quar ...
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
Accessnewswire· 2025-10-29 19:30
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) lesions over lifetime PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 29, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to anno ...
HOLDCO ASSET MANAGEMENT RELEASES PRESENTATION PREVIOUSLY PROVIDED TO THE BOARD OF DIRECTORS OF COLUMBIA BANKING SYSTEM, INC. ON SEPTEMBER 14, 2025
Prnewswire· 2025-10-29 19:30
Accessibility StatementSkip Navigation FORT LAUDERDALE, Fla., Oct. 29, 2025 /PRNewswire/ -- Today, HoldCo Asset Management, LP ("HoldCo"), a Florida-based investment firm managing approximately $2.6 billion in regulatory assets under management, released a follow-up presentation to the Board of Directors of Columbia Banking System, Inc., attaching a copy of the presentation previously provided to the Board of Directors on September 14, 2025 entitled "Failed Gambles Borne Solely By Owners – Protective Coven ...
Watsco Reports Record Third Quarter Gross Profit, Gross Margin and Operating Cash Flow in Challenging Market Conditions
Globenewswire· 2025-10-29 19:30
Strong Balance Sheet and Market-Leading Technologies Enable Continued Investments in GrowthMIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Watsco, Inc. (NYSE: WSO) announced its operating results for the third quarter and nine-month period ended September 30, 2025. The Company also provided updates related to innovation and technology, business trends and long-term growth opportunities. Watsco is the largest distributor in the highly-fragmented $74 billion North American market for HVAC products. Since entering di ...
NAPCO Security Technologies to Announce Fiscal First Quarter 2026 Results Monday, November 3, 2025
Prnewswire· 2025-10-29 19:30
Accessibility StatementSkip Navigation AMITYVILLE, N.Y., Oct. 29, 2025 /PRNewswire/ -- NAPCO Security Technologies, Inc. (NASDAQ: NSSC), one of the leading designers and manufacturers of high-tech electronic security devices, wireless recurring communication services for intrusion, fire alarm, access control and locking systems as well as a leading provider of school safety solutions will release financial results for its Fiscal First Quarter 2026, which ended September 30, 2025, on Monday November 3, 2025 ...
Stock Yards Bancorp Reports Record Third Quarter Earnings of $36.2 Million or $1.23 Per Diluted Share
Globenewswire· 2025-10-29 19:30
Results Highlighted by Solid Loan and Deposit GrowthLOUISVILLE, Ky., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today reported record earnings of $36.2 million, or $1.23 per diluted share, for the third quarter ended September 30, 2025. This compares to net income of $29.4 milli ...
Seabridge Gold Recovers $4.4 Million after Successfully Challenging Tax Ruling in BC Supreme Court
Newsfile· 2025-10-29 19:30
Seabridge Gold Recovers $4.4 Million after Successfully Challenging Tax Ruling in BC Supreme CourtFurther Recoveries AnticipatedOctober 29, 2025 7:30 AM EDT | Source: Seabridge Gold Inc.Toronto, Ontario--(Newsfile Corp. - October 29, 2025) - Seabridge Gold Inc. (TSX: SEA) (NYSE: SA) (the "Company") announced today that the Company has received $4.4 million in recovered funds from the Canada Revenue Agency ("CRA") as a result of the Supreme Court of BC ("SCBC") reversing CRA's previous decision ...
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome
Globenewswire· 2025-10-29 19:30
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) lesions over lifetimePHILADELPHIA, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce a strategic c ...